Areas of Expertise

Dr George is experienced in managing all respiratory conditions, with specialist expertise in interstitial lung diseases including:

• Idiopathic pulmonary fibrosis (IPF)
• Sarcoidosis
• Hypersensitivity pneumonitis
• Autoimmune-related lung conditions
• Lung diseases due to scleroderma and rheumatoid arthritis
• Smoking-related lung diseases
• Post-COVID respiratory complications

About Dr Peter George

Dr Peter George is a consultant respiratory physician who is experienced in managing all respiratory conditions and has specialist expertise in conditions which result in lung inflammation and scarring – interstitial lung disease and pulmonary fibrosis.

Alongside his work at OneWelbeck, his NHS base is the Royal Brompton Hospital, a highly specialised heart and lung hospital where he is a member of the interstitial lung disease unit, the largest of its nature in Europe.

As an Honorary Clinical Senior Lecturer at Imperial College London, Dr George continues to be highly active in basic science and clinical research recruiting patients to trials of new therapies, supervising PhD students and publishing his research in the most prestigious medical journals.

Personal Biography

After completing his undergraduate studies at Imperial College London, Dr Peter George trained in respiratory and general medicine at the most prestigious centres in London. He completed his specialist training in interstitial lung disease at the Hammersmith and Royal Brompton hospitals in London and at the National Jewish Health Hospital in Denver, Colorado, USA.

In 2009, Dr George was awarded an academic clinical fellowship in respiratory medicine at Imperial College London. With funding from the Medical Research Council, Dr George completed his PhD on the role of the immune system in pulmonary inflammation.

Reviews

Research Highlights

Key Publications

• Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities
  George PM, Spagnolo P, Kreuter M, Altinisik G, Bonifazi M, Martinez FJ et al.
  Lancet Respir Med. 2020 Sep;8(9):925-934.
• Respiratory follow-up of patients with COVID-19 pneumonia.
  George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I et al.
  Thorax. 2020 Nov;75(11):1009-1016
• Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
  George PM, Wells AU, Jenkins RG.
  Lancet Respir Med. 2020 Aug;8(8):807-815